Company / Interest Expense
GYRE THERAPEUTICS, INC. Interest Expense History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$726.0K
FY2023
5-year range
$726.0K / $726.0K
FY2022-FY2023
Trend
+0.0%
vs FY2022
Sector context
#37 of 44
Health Care
What the data says
GYRE THERAPEUTICS, INC.'s interest expense of $726,000 is lower than 84% of companies in the Health Care sector (FY2023).
Based on SEC 10-K filings.
$726,000 in FY2023.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 44This company $726.0K Sector average $291.0M
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2023, interest expense increased 0.0% year-over-year.
- Ranks #37 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $726.0K | +0.0% |
| FY2022 | $726.0K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026